Azeliragon (TTP488)
Azeliragon (TTP488, PF-04494700) is an orally bioavailable small molecule that inhibits the receptor for advanced glycation endproducts (RAGE), which is an immunoglobulin-like cell surface receptor overexpressed in brain tissues of patients with AD.
Trivial name | PF-04494700 |
Catalog Number | S6415 |
Molecular Formula | C32H38ClN3O2 |
CAS# | 603148-36-3 |
Inchi | InChI=1S/C32H38ClN3O2/c1-4-7-9-32-34-31(25-10-16-28(17-11-25)37-23-8-22-35(5-2)6-3)24-36(32)27-14-20-30(21-15-27)38-29-18-12-26(33)13-19-29/h10-21,24H,4-9,22-23H2,1-3H3 |
Inchi Key | KJNNWYBAOPXVJY-UHFFFAOYSA-N |
SMILES | CCCCC1=NC(=CN1C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C4=CC=C(C=C4)OCCCN(CC)CC |
Size | 25mg |
Supplier Page | http://www.selleckchem.com/products/azeliragon.html |
Additional Information | https://file.selleck.cn/downloads/struct/azeliragon-chemical-structure-s6415.gif |